top of page
Browse by category
Search


Head-to-head study shows five times more weight loss with surgery than GLP-1s after two years
Sleeve gastrectomy and gastric bypass were associated with about five-times more weight loss than weekly injections of GLP-1 receptor...


Self-esteem surges within one year of BMS
Self-esteem scores more than doubled within one year of Bariatric and metabolic surgery (BMS) according to a new study presented at the...


Psychiatric disorders less likely after BMS than treatment with GLP-1s
People who have bariatric and metabolic surgery (BMS) are significantly less likely to develop psychiatric disorders compared to those...


Semaglutide effective for people with schizophrenia
Diabetic weight-loss medications are effective for people with schizophrenia without affecting psychotic symptoms, according to...


Study highlights psychosocial predictors of bariatric surgery revisions
Several psychosocial and lifestyle factors influence post-surgical success in patients undergoing bariatric and metabolic surgery (BMS),...


Higher BMI associated with higher complication rate post-BMS
The higher a person’s body mass index (BMI), the higher their risk for complications after bariatric surgery, especially those with BMI...


Accreditation process drives surgical quality improvement
About 800 US hospitals have earned accreditation from the American College of Surgeons (ACS) between 2017 and 2023 through programs aimed...


AMA passes resolution calling for expanded access to AOMs
The American Medical Association (AMA) House of Delegates has passed the Endocrine Society’s resolution to improve access to anti-obesity...


Tufts chemists design a next generation of weight loss drugs
Tufts researchers led by Krishna Kumar, Robinson Professor of Chemistry, have designed a new, next-generation compound with hopes that it...


Injectable medications for obesity produce smaller weight loss in a real-world setting, compared to randomised clinical trials
A Cleveland Clinic study shows that semaglutide and tirzepatide – injectable GLP-1 drugs for obesity – produce smaller weight loss in a...
Browse by tag






bottom of page
